Tirzepatide – 30mg
$400.00
Tirzepatide is a novel dual GLP-1 and GIP receptor agonist that is emerging as a promising peptide for the management of obesity and metabolic health in research settings. This innovative compound functions by mimicking the actions of both glucagon-like peptide-1 (GLP-1) and gastric inhibitory polypeptide (GIP), promoting insulin secretion, reducing appetite, and enhancing fat metabolism. Research has shown that Tirzepatide may lead to significant weight loss and improved glycemic control.
Buy Tirzepatide, as studies continue to explore its benefits it holds promise in the fields of weight management and metabolic disease research.
Research Peptides
99% Purity
3rd Party Tested
USA Made
Note: Peptides will arrive in a lyophilized (powder) form for maximum stability
The peptides are available for research and laboratory purposes only. Please review and ahere to our Terms and Conditions before ordering.
- Description
- Certificate of Analysis
Tirzepatide Structure
Source: Wikipedia
What is Tirzepatide?
Tirzepatide is a novel peptide that acts as a dual agonist, targeting both the glucagon-like peptide-1 (GLP-1) receptor and the glucose-dependent insulinotropic polypeptide (GIP) receptor. This innovative approach has garnered significant attention for its potential to improve glycemic control and promote weight loss in research settings.
Introduction to Tirzepatide
The Origin of Tirzepatide
Tirzepatide was developed as a part of ongoing research into therapies for type 2 diabetes and obesity. Its unique mechanism of action, combining the effects of GLP-1 and GIP, has positioned it as a significant advancement in the field of metabolic disease management research.
Unique Composition
Tirzepatide is a synthetic peptide composed of 39 amino acids. Its structure allows it to mimic the natural hormones GLP-1 and GIP, which play essential roles in regulating blood sugar levels and appetite.
How Tirzepatide Works
Mechanism of Action
Tirzepatide functions by activating GLP-1 and GIP receptors, leading to increased insulin secretion, reduced glucagon levels, and enhanced satiety. This dual action may help regulate blood glucose levels and support weight loss by decreasing appetite and increasing energy expenditure in studies.
Influencing Metabolic Health
By addressing both glycemic control and appetite regulation, Tirzepatide helps improve overall metabolic health, making it a valuable option for researchers studying type 2 diabetes and obesity.
Benefits of Tirzepatide
Improved Glycemic Control
One of the primary benefits of Tirzepatide is its ability to significantly improve glycemic control in type 2 diabetes. By enhancing insulin secretion and reducing glucose production, it helps maintain more stable blood sugar levels in research settings.
Cardiovascular Benefits
Emerging research suggests that Tirzepatide may have cardiovascular benefits, including improvements in blood pressure and lipid profiles.
Why Tirzepatide is Different from Other Peptides
What sets Tirzepatide apart is its dual action on both GLP-1 and GIP receptors. While many peptides target a single pathway, Tirzepatide’s ability to influence multiple mechanisms related to glucose metabolism and appetite regulation offers a multifaceted approach to managing type 2 diabetes and obesity in research.
For Research Use Only
